Mistletoe lectins: Telomerase inhibitors in alternative cancer therapy

Drug Discovery Today

Volumn 7, Issue 17, 2002, Pages 896-897

  Li, Shi Sheng ^a,b  

^a UPPSALA UNIVERSITY   (Sweden)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CASPASE; CYTOCHROME C; RIBOSOME INACTIVATING PROTEIN; TELOMERASE INHIBITOR; VISCUM ALBUM EXTRACT; VISCUM ALBUM LECTIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CELL DEATH; CONCENTRATION RESPONSE; DRUG MECHANISM; DRUG PROTEIN BINDING; DRUG TARGETING; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME INHIBITION; ENZYME RELEASE; GENETIC STABILITY; LYMPHOCYTE; MITOCHONDRION; PROTEIN FUNCTION; SHORT SURVEY; TELOMERE; TUMOR CELL; VISCUM ALBUM;

EID: 0036742784     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6446(02)02414-5     Document Type: Note

References (13)

1. Kienle G.S. The story behind mistletoe: a European remedy from anthroposophical medicine. Altern. Ther. Health Med. 5:1999;34-36.
2. Bocci V. Mistletoe (Viscum album) lectins as cytokine inducers and immunoadjuvant in tumor therapy. A review. J. Biol. Regul. Homeost. Agents. 7:1993;1-6.
3. Holtskog R., et al. Characterization of a toxic lectin in Iscador®, a mistletoe preparation with alleged cancerostatic properties. Oncology. 45:1988;172-179.
4. Valentiner U., et al. The cytotoxic effect of mistletoe lectins I, II and III on sensitive and multidrug resistant human colon cancer cell lines in vitro. Toxicology. 171:2002;187-199.
5. Büssing A., et al. Induction of Fas ligand (CD95L) by the toxic mistletoe lectins in human lymphocytes. Anticancer Res. 19:1999;1785-1790.
6. Lyu S.Y., et al. Involvement of caspase-3 in apoptosis induced by Viscum album var. coloratum agglutinin in HL-60 cells. Biosci. Biotechnol. Biochem. 65:2001;534-541.
7. Bantel H., et al. Mistletoe lectin activates caspase-8/FLICE independently of death receptor signaling and enhances anticancer drug-induced apoptosis. Cancer Res. 59:1999;2083-2090.
8. Park R., et al. Activation of c-Jun N-terminal kinase 1 (JNK1) in mistletoe lectin II-induced apoptosis of human myeloleukemic U937 cells. Biochem. Pharmacol. 60:2000;1685-1691.
9. Kim M.S., et al. Activation of caspase cascades in Korean mistletoe (Viscum album var. coloratum) lectin-II-induced apoptosis of human myeloleukemic U937 cells. Gen. Pharmacol. 34:2000;349-355.
10. Lyu S.Y., et al. Korean mistletoe lectin-induced apoptosis in hepatocarcinoma cells is associated with inhibition of telomerase via mitochondria controlled pathway independent of p53. Arch. Pharm. Res. 25:2002;93-101.
11. Levy M.Z., et al. Telomere end-replication problem and cell aging. J. Mol. Biol. 225:1992;951-960.
12. White L.K., et al. Telomerase inhibitors. Trends Biotechnol. 19:2001;114-120.
13. Shay J.W., et al. Telomerase and cancer. Hum. Mol. Genet. 10:2001;677-685.